CYP2D6 Genotype Predicts Tamoxifen Discontinuation and Prognosis in Patients With Breast Cancer

PURPOSE: To examine the association between CYP2D6 genotype, discontinuation of tamoxifen therapy, and prognosis for breast cancer. PATIENTS AND METHODS: We conducted a prospective-retrospective study linking data from a clinical breast cancer register, the Swedish Prescribed Drug Register, and self...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Wei, Grassmann, Felix, Eriksson, Mikael, Eliasson, Erik, Margolin, Sara, Thorén, Linda, Hall, Per, Czene, Kamila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2020
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7030887/
https://www.ncbi.nlm.nih.gov/pubmed/31800347
http://dx.doi.org/10.1200/JCO.19.01535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7030887/
https://www.ncbi.nlm.nih.gov/pubmed/31800347
http://dx.doi.org/10.1200/JCO.19.01535

Ejemplares similares